https://www.sciencedirect.com/journal/acta-pharmaceutica-sinica-b/vol/15/issue/7
Acta Pharmaceutica Sinica B (APSB) was founded with the goal of creating a global high-level forum centred around drug discovery and pharmaceutical research/application. APSB was included by Chemical Abstracts in 2011, accepted by PubMed Central in 2015, indexed by Science Citation Index in 2017 and has evolved to become one of the most important international journals in the field of pharmaceutical sciences.
APSB is a monthly journal, in English, which publishes significant original research articles, rapid communications and high-quality reviews of recent advances in all areas of pharmaceutical sciences — including pharmacology, pharmaceutics, medicinal chemistry, natural products, pharmacognosy, pharmaceutical analysis and pharmacokinetics.
Articles of interest in this issue include:

Trends in intestinal aging: From underlying mechanisms to therapeutic strategies by Yajun Wang, Xueni Zhang, Mengli Qing and colleagues, (https://doi.org/10.1016/j.apsb.2025.05.011). Anti-intestinal aging can be used as an important strategy for reducing frailty and promoting longevity. This review summarizes the latest advances in the mechanisms and therapeutic strategies of intestinal aging.
Single-cell RNA sequencing reveals Shen-Bai-Jie-Du decoction retards colorectal tumorigenesis by regulating the TMEM131–TNF signaling pathway-mediated differentiation of immunosuppressive dendritic cells by Yuquan Tao, Yinuo Ma, Limei Gu and colleagues, (https://doi.org/10.1016/j.apsb.2025.05.013). Single-cell RNA sequencing in Apc^Min/+ mice and clinical specimens demonstrates that Shen-Bai-Jie-Du decoction inhibits colorectal tumorigenesis by regulating TMEM131–TNF signaling pathway-mediated differentiation of immunosuppressive dendritic cells.
CMD-OPT model enables the discovery of a potent and selective RIPK2 inhibitor as preclinical candidate for the treatment of acute liver injury by Yong Chen, Xue Yuan, Wei Yan and colleagues, (https://doi.org/10.1016/j.apsb.2025.05.003). RP20, as a promising preclinical RIPK2 inhibitor candidate, exhibited excellent kinase selectivity, perfect oral pharmacokinetics, and high safety. It exhibited better therapeutic effects than N-acetylcysteine and GSK2983559 in APAP-induced ALI model. This represents the inaugural deployment of RIPK2 inhibitors in the treatment of ALI, thereby offering a novel therapeutic avenue for clinical application.
Other articles include:

Reviews
Artificial intelligence and anti-cancer drugs' response
Xinrui Long, Kai Sun, Sicen Lai, Yuancheng Liu, ... Kai Huang

Indoleamine-2,3-dioxygenase: An important controller in maintaining mesenchymal stem cell-mediated immunomodulatory homeostasis
Yufei Hui, Xue Jiao, Li Yang, Dejin Lu, ... Minjie Wei

Immune organoid for cancer immunotherapy
Xiao-He Wang, Wu-Yin Wang, Zhi-Jun Sun

Unraveling the therapeutic landscape of approved non-peptide macrocycles
Zhonghua Li, Zhenqiang Zhang, Bin Yu

Extracellular vesicles as biomarkers and drug delivery systems for tumor
Xue Wang, Wenjing Chen, Wei Zeng, Kuanhan Feng, ... Ruoning Wang

Nanomedicine-induced pyroptosis for anti-tumor immunotherapy: Mechanism analysis and application prospects
Yuelin Huang, Chunting Wang, Yanhong Chen, Dengbin Wang, Defan Yao

Advances in research on biomaterials and stem cell/exosome-based strategies in the treatment of traumatic brain injury
Wenya Chi, Yingying He, Shuisheng Chen, Lingyi Guo, ... Yuan Yu

Original articles
Enzyme-independent functions of HDAC3 in the adult heart
Sichong Qian, Chen Zhang, Wenbo Li, Shiyang Song, ... Zheng Sun

Antisense oligonucleotides targeting IRF4 alleviate psoriasis
Yanxia Yu, Yirui Wang, Weiwei Chen, Chang Zhang, ... Liangdan Sun

Melatonin receptor 1a alleviates sleep fragmentation-aggravated testicular injury in T2DM by suppression of TAB1/TAK1 complex through FGFR1
Xiaohui Zhang, Xinyu Tang, Ting Gao, Yuanfang Guo, ... Junlian Gu

RXRα modulates hepatic stellate cell activation and liver fibrosis by targeting CaMKKβ–AMPKα axis
Lijun Cai, Meimei Yin, Shuangzhou Peng, Fen Lin, ... Xiao-Kun Zhang

Linagliptin synergizes with cPLA2 inhibition to enhance temozolomide efficacy by interrupting DPP4-mediated EGFR stabilization in glioma
Dongyuan Su, Biao Hong, Shixue Yang, Jixing Zhao, ... Chunsheng Kang

Discovery of Yersinia LcrV as a novel biased agonist of formyl peptide receptor 1 to bi-directionally modulate intracellular kinases in triple-negative breast cancer
Yunjun Ge, Huiwen Guan, Ting Li, Jie Wang, ... Guosheng Wu

Cytoplasmic and nuclear NFATc3 cooperatively contributes to vascular smooth muscle cell dysfunction and drives aortic aneurysm and dissection
Xiu Liu, Li Zhao, Deshen Liu, Lingna Zhao, ... Shaoyi Zheng

Design, synthesis, and antitumor activity of novel thioheterocyclic nucleoside derivatives by suppressing the c-MYC pathway
Xian-Jia Li, Ke-Xin Huang, Ke-Xin Wang, Ru Liu, ... Hai-Ming Guo

Anacyphrethines A and B as potent analgesics: Multiple ion channel inhibitors with an unprecedented chemical architecture
Hui Chen, Hanqi Zhang, Chao Niu, Bianlin Wang, ... Haji Akber Aisa

Autonomous drug delivery and scar microenvironment remodeling using micromotor-driven microneedles for hypertrophic scars therapy
Ting Wen, Yanping Fu, Xiangting Yi, Ying Sun, ... Guilan Quan

Engineered platelet-derived exosomal spheres for enhanced tumor penetration and extended circulation in melanoma immunotherapy
Jian Zhao, Xinyan Lv, Qi Lu, Kaiyuan Wang, ... Jin Sun

A high clinically translatable strategy to anti-aging using hyaluronic acid and silk fibroin co-crosslinked hydrogels as dermal regenerative fillers
Jialing Cheng, Zhiyang Chen, Demin Lin, Yanfang Yang, ... Yuling Liu

High intensity forced ultrasound-driven ferroptosis as a strategy for anti-tumor immune priming
Xuejing Li, Jiayi Wu, Ruizhe Xu, Xifeng Qin, ... Zhiqing Pang

Polymer-assisted PD-L1 degradation and targeted photodynamic therapy synergize to suppress immunodeficient tumors
Changyong Guo, Shipeng He, Huaxing Shen, Wei Cong, ... Honggang Hu

Letter to the Editor
Non-blocking anti-PD-L1 nanobody conjugated to TLR7 agonist mediates macrophage/NK cell-associated antitumor effects
Chao Hu, Chen Chen, Xiaolu Yu, Zhiying Li, ... Likun Gong

Highlights
Reshaping antivenom therapy: A triple-synergy strategy featuring broadly neutralizing antibodies and a small-molecule PLA₂ inhibitor
Yangyihua Zhou, Ning Shi, Xiang Gao, Longlong Luo

Sympathetic nerve activity in obesity-associated insulin resistance
Shuchou Xia, Huili Wu, Jianping Ye

Editorials
Traditional Chinese medicine in the early prevention of colorectal cancer from the perspective of tumor microenvironment
Huan Tang, Jigang Wang

A transformer-based strategy to develop RP20 as a potent RIPK2 inhibitor for acetaminophen-induced acute liver injury
Liang Ouyang
# # # #
The Journal of the Institute of Materia Medica, the Chinese Academy of Medical Sciences and the Chinese Pharmaceutical Association.
For more information please visit https://www.journals.elsevier.com/acta-pharmaceutica-sinica-b/
Editorial Board: https://www.journals.elsevier.com/acta-pharmaceutica-sinica-b/editorial-board

APSB is available on ScienceDirect (https://www.sciencedirect.com/journal/acta-pharmaceutica-sinica-b).

Submissions to APSB may be made using Editorial Manager® (https://www.editorialmanager.com/apsb/default.aspx).

CiteScore: 24.3
Impact Factor: 14.6 (Top 6 journal in the category of Pharmacology and pharmacy)
JIF without self-citation: 13.8

ISSN 2211-3835
# # # # #